Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Acer Therapeutics stock

Learn how to easily invest in Acer Therapeutics stock.

Acer Therapeutics Inc is a biotechnology business based in the US. Acer Therapeutics shares (ACER) are listed on the NASDAQ and all prices are listed in US Dollars. Acer Therapeutics employs 30 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Acer Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ACER – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Acer Therapeutics stock price (NASDAQ: ACER)

Use our graph to track the performance of ACER stocks over time.

Acer Therapeutics shares at a glance

Information last updated 2022-01-16.
Latest market close$2.12
52-week range$1.68 - $5.39
50-day moving average $2.25
200-day moving average $2.56
Wall St. target price$11.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.24

Buy Acer Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Stocks
$0
0%
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$0
$1 per month
$5
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Public
Stocks, ETFs, Cryptocurrency
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Acer Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Acer Therapeutics price performance over time

Historical closes compared with the close of $2.12 from 2022-01-21

1 week (2022-01-13) -5.78%
1 month (2021-12-18) N/A
3 months (2021-10-18) N/A
6 months (2021-07-22) -12.40%
1 year (2021-01-22) -42.23%
2 years (2020-01-22) -52.89%
3 years (2019-01-22) 24.8
5 years (2017-01-20) 134.25%

Acer Therapeutics financials

Revenue TTM $900,000
Gross profit TTM $0
Return on assets TTM -45.87%
Return on equity TTM -271.41%
Profit margin 0%
Book value $0.15
Market capitalisation $31.6 million

TTM: trailing 12 months

Acer Therapeutics share dividends

We're not expecting Acer Therapeutics to pay a dividend over the next 12 months.

Have Acer Therapeutics's shares ever split?

Acer Therapeutics's shares were split on a 96:1000 basis on 20 September 2017. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 96 shares. This wouldn't directly have changed the overall worth of your Acer Therapeutics shares – just the quantity. However, indirectly, the new 941.7% higher share price could have impacted the market appetite for Acer Therapeutics shares which in turn could have impacted Acer Therapeutics's share price.

Acer Therapeutics share price volatility

Over the last 12 months, Acer Therapeutics's shares have ranged in value from as little as $1.68 up to $5.39. A popular way to gauge a stock's volatility is its "beta".

ACER.US volatility(beta: 1.11)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acer Therapeutics's is 1.1061. This would suggest that Acer Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Acer Therapeutics overview

Acer Therapeutics Inc. , a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was founded in 1991 and is headquartered in Newton, Massachusetts. .

Frequently asked questions

What percentage of Acer Therapeutics is owned by insiders or institutions?
Currently 15.409% of Acer Therapeutics shares are held by insiders and 29.393% by institutions.
How many people work for Acer Therapeutics?
Latest data suggests 30 work at Acer Therapeutics.
When does the fiscal year end for Acer Therapeutics?
Acer Therapeutics's fiscal year ends in December.
Where is Acer Therapeutics based?
Acer Therapeutics's address is: One Gateway Center, Newton, MA, United States, 02458
What is Acer Therapeutics's ISIN number?
Acer Therapeutics's international securities identification number is: US00444P1084
What is Acer Therapeutics's CUSIP number?
Acer Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00444P108

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site